cefmenoxime
Enable an AI agent to recognise cefmenoxime, assess the identity and condition of a material containing it, and determine which analytical, handling or downstream-use decisions the evidence supports.
Bundle → Layer → Finding → Questions Filled
6 bundles · 11 layers · 18 findings · 28 questions
Cefmenoxime identity and boundaries Establish which molecular entity and related material form a record denotes.
Molecular recognition
Recognise cefmenoxime using its complete structure rather than antibiotic class alone.
Structure-based identity
Identity evidence should resolve the cephem stereochemistry, oxime configuration and substituents against an authoritative cefmenoxime reference.
- Which authoritative structure specifies the stereochemistry and oxime configuration accepted for cefmenoxime? definition
- Which analytical results distinguish this material from cefminox, other cephalosporins and cefmenoxime isomers? measurement
Parent and salt mapping
Keep related forms attached to the registered substance while preserving their chemical differences.
Form-specific identifiers
Each identifier and composition statement must identify whether it describes cefmenoxime itself or a specified salt, hydrate or solvate.
- Does the supplied CAS, PubChem or EC identifier denote the parent, hydrochloride or another explicitly documented form? boundary
- What source establishes the counterion ratio and hydration state used to convert this material to cefmenoxime equivalents? provenance
Cefmenoxime lot quality Determine the amount, integrity and intended-use suitability of cefmenoxime material.
Assay and reference basis
Make reported cefmenoxime content traceable and comparable.
Interpretable cefmenoxime assay
Content measurements need a reference standard, validated method and explicit correction for chemical form and moisture.
- Is the assay expressed as cefmenoxime parent equivalent, salt content, dry-basis content or as-received content? measurement
- Which reference-standard lot and assigned potency support the reported result? provenance
Impurities and grade
Connect impurity evidence to the specification required by the intended use.
Grade supported by results
Evaluate related substances, water, solvents and any required microbiological attributes against a named specification; antibiotic activity does not demonstrate sterility.
- Which cefmenoxime-related impurities are identified, which remain unidentified, and what limits and response factors apply? measurement
- Which documented grade requirements must this lot satisfy before the proposed analytical or pharmaceutical use? action
Cefmenoxime physical state and stability Describe the actual material state and evidence for retaining cefmenoxime quality over time.
Solid-form properties
Characterise cefmenoxime solids without borrowing constants from a different salt or hydration state.
Conditioned physical properties
Attach solubility, water uptake and thermal observations to the characterised form and measurement conditions.
- Which solid form and water content were present when solubility or thermal behaviour was measured? measurement
- Does the reported thermal event represent melting, solvent loss or decomposition, and what method supports that interpretation? measurement
Solution integrity over time
Evaluate cefmenoxime preparations using condition-specific chemical stability evidence.
Validated preparation window
Any permitted preparation or holding interval should be supported by cefmenoxime assay and degradation measurements under matching conditions.
- What cefmenoxime assay and impurity changes occur at the proposed pH, solvent, concentration, temperature and light exposure? measurement
- What evidence supports the proposed container, storage duration and acceptance criteria for this preparation? action
Cefmenoxime antibacterial evidence Represent the evidence connecting cefmenoxime identity and integrity to measured antibacterial behaviour.
Mechanism evidence
Separate cefmenoxime-specific experimental evidence from claims inherited from the broader antibiotic class.
Target and resistance context
Record the experimental basis for target interactions and resistance-related behaviour with the tested organism or enzyme.
- Which primary studies directly establish cefmenoxime interactions with bacterial penicillin-binding proteins? provenance
- Which measured resistance mechanisms or enzyme interactions limit the applicability of a cefmenoxime activity claim? boundary
Activity measurement context
Keep susceptibility and potency observations tied to reproducible assay conditions.
Bounded activity interpretation
Activity records require organism identity, method, controls and concentration basis; clinical interpretation requires separate applicable evidence.
- What strain, medium, inoculum, endpoint and cefmenoxime concentration basis produced this MIC or potency result? measurement
- Is a current cefmenoxime-specific interpretive criterion available for this organism and method, or must the result remain uninterpreted? boundary
Cefmenoxime handling and use controls Connect substance handling and release decisions to form-specific safety and regulatory evidence.
Hazard and exposure evidence
Identify documented hazards and controls for the actual cefmenoxime material being handled.
Applicable safety record
Use a current, applicable safety record to establish classification, exposure controls and disposal requirements without inventing absent limits.
- Which SDS revision covers this cefmenoxime form and reports its GHS classification and sensitisation-related precautions? provenance
- What documented exposure limits, containment measures and antibiotic-waste procedures apply to the proposed operation? action
Use eligibility and disposition
Keep substance recognition separate from decisions to release a lot for a regulated or research use.
Evidence-backed release
Disposition depends on intended use, jurisdiction, quality results and storage history; product authorisations remain linked external records.
- Which current specification or regulatory record establishes requirements for this cefmenoxime material in the intended jurisdiction and use? provenance
- Do the lot results and storage history support release, or is quarantine, retesting or rejection required? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these check these first hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these kinds and varieties hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these identifiers and schemes hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these real-world use hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these typical measurements hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these failure modes and hazards hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these regional variation hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of cefmenoxime this model covers, and on what evidence? provenance
Classifiers Filled
- Family
- Thing Registry
- Category
- Physical world and living systems
- Entry kind
- thing
- Plane
- PHY
- Domain
- PHY.MAT
What it is Filled
Cefmenoxime is a semisynthetic third-generation cephalosporin beta-lactam antibiotic that inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins.
In scope
- Cefmenoxime molecular identity, stereochemistry and identifier mappings
- Relationships between cefmenoxime and explicitly characterised salt, hydrate or solvate forms
- Lot-specific assay, impurities, water content and intended-use grade
- Physical state, solution behaviour and stability under recorded conditions
- Antibacterial activity evidence and substance-level handling constraints
Out of scope
- Finished medicinal products, excipient compositions and packaging specifications
- Patient-specific prescribing, dosing and treatment selection
- Manufacturing routes, production equipment and process validation
- Independent models of other cephalosporins or cefminox
- Organism taxonomy and general antimicrobial-resistance surveillance
Why it exists Filled
Enable an AI agent to recognise cefmenoxime, assess the identity and condition of a material containing it, and determine which analytical, handling or downstream-use decisions the evidence supports.
Distinguishing features Filled
- Match the complete molecular structure and stereochemistry, with parent formula C16H17N9O5S3 and PubChem CID 9570757 as corroborating identifiers. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Cefmenoxime)
- Require the cefmenoxime combination of a 7-position aminothiazolyl methoxyimino side chain and a 3-position methylthiotetrazole-containing substituent; a cephalosporin scaffold alone is insufficient. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Cefmenoxime)
- Distinguish cefminox by its different molecular formula and side-chain structure rather than accepting the similar name as a synonym. [PubChem cefminox](https://pubchem.ncbi.nlm.nih.gov/compound/Cefminox)
- Distinguish the parent substance from hydrochloride material: PubChem separately records cefmenoxime hydrochloride as CID 11954009 with formula C32H35ClN18O10S6, requiring explicit stoichiometry rather than an assumed 1:1 salt. [PubChem hydrochloride](https://pubchem.ncbi.nlm.nih.gov/compound/11954009)
- Require an analytical identity match for a material lot; a product name, antibiotic-class label or antibacterial response alone does not establish cefmenoxime identity.
What robots and AI may and may not do Filled
Must not
- Recommend, dose or supply it to a person without a prescriber's decision.
- Advise its use for viral infections or without a confirmed need.
- Ignore a reported beta-lactam allergy.
- Overlook the risk of reactions with alcohol linked to its side chain.
Only with a human decision
- Any decision to start, stop or change antibiotic treatment.
May
- Describe cefmenoxime's class, mechanism and clinical use from authoritative sources.
- Note that availability differs by country.
Moral aspects Filled
- Unnecessary antibiotic use drives resistance that harms the wider community.
Who is affected
- Patients
- Communities exposed to resistant bacteria
- Prescribers
Owners Filled
Steward
The marketing authorisation holder where it is licensed; the prescriber answers for each use.
Master systems
- National medicines registers
Links to other meta-models Filled
parent
- Q11173 - registry parent class
What else AI and robots need to interact with it Filled
Identity and identifiers required Filled
- Vercy registry: vr.tr.cefmenoxime
- Wikidata: Q4921166 (https://www.wikidata.org/wiki/Q4921166)
Direct properties required Filled
- Molecular identity: Complete stereochemical structure; parent formula C16H17N9O5S3; PubChem CID 9570757
- Identifier applicability: CAS, PubChem, EC or other identifier linked to its issuing source and exact chemical form
- Material form: Parent, specified salt, hydrate or solvate; stoichiometry; solid-form assignment or unknown
- Cefmenoxime content: % m/m or mg/g; as received, dry basis or parent equivalent; method and uncertainty
- Related substances: Individual and total impurities in % with method, reporting basis and identification confidence
- Water and residual solvents: Water in % m/m; named solvents in mg/kg; analytical method
- Physical and solution state: Solid or solution; solvent, concentration, pH, temperature, appearance and elapsed time
- Solubility and thermal behaviour: Solubility in mg/mL with conditions; thermal events in °C with method and decomposition assessment
- Antibacterial activity: MIC in µg/mL or validated potency units; organism, strain, method and material basis
- Use and handling status: Research, reference or pharmaceutical grade; released, quarantined or rejected; applicable SDS and jurisdiction
Recognition required Filled
- A powder for injection or an eye or ear preparation; identity is confirmed by label and pharmacy records.
Capabilities and actions required Filled
- Resolve a cefmenoxime-labelled record or sample against a verified structure and form-specific identifiers.
- Calculate cefmenoxime parent-equivalent quantities when salt stoichiometry, water content and assay basis are established.
- Assess a lot against an explicitly selected cefmenoxime specification and flag missing or failed evidence.
- Compare stability and compatibility evidence for a proposed solvent, concentration and storage interval.
- Interpret antibacterial measurements within their organism and assay conditions.
- Route material to release, quarantine, further testing or documented disposal based on applicable evidence.
Hazards and failure modes required Filled
- Allergic reactions, including in people with penicillin allergy.
- Flushing and sickness when combined with alcohol.
- Bleeding tendency from effects on clotting.
Standards and interfaces required Filled
- The Anatomical Therapeutic Chemical classification, maintained by the World Health Organization Collaborating Centre for Drug Statistics Methodology, classifies cefmenoxime among third-generation cephalosporins.
Context of use required Filled
- Cefmenoxime is encountered in antibacterial medicine, pharmaceutical analysis and research on cephalosporin antibiotics.
- Material testing distinguishes the active compound and its pharmaceutical forms while assessing purity, stability and suitability for an intended use.
Sources Filled
- Wikidata item Q4921166: cefmenoxime - identity and sense of the item
- Wikipedia: Cefmenoxime - general description of the item
Open questions
- Which authoritative CAS and EC records apply to cefmenoxime parent and the relevant hydrochloride forms, and how do they distinguish stoichiometry and hydration?
- Which current cefmenoxime monographs or validated specifications define assay, related substances, reference standards and grade-dependent acceptance limits?
- What experimentally supported solid-form, solubility, thermal and solution-stability data exist for each relevant cefmenoxime form?
- Which current jurisdiction-specific SDS classifications and occupational exposure limits, if any, apply to the actual supplied material?
- Which primary cefmenoxime activity studies and current susceptibility standards support organism-specific interpretation without extrapolation from other cephalosporins?
Machine files
Provenance
thing registry research (pass 2) · unreviewed
Built from: models/things/publications/thing-q4921166/spec.json